When to seek immediate medical attention: Severe abdominal pain that doesn't resolve, possibly radiating to the back (potential pancreatitis) Persistent nausea and vomiting preventing adequate fluid intake (dehydration risk) Signs of allergic reaction: difficulty breathing, swelling of face or throat, severe rash Symptoms of thyroid tumors: lump in neck, hoarseness, difficulty swallowing (rare but serious) Severe hypoglycemia symptoms when used with insulin or sulfonylureas: confusion, seizures, loss of consciousness Changes in vision or eye pain (potential diabetic retinopathy complications, particularly with rapid improvement in blood glucose) Signs of kidney problems: decreased urination, swelling in legs or feet, unusual fatigue Symptoms of gallbladder problems: pain in right or middle upper abdomen, fever, yellowing of skin/eyes These medications carry a boxed warning regarding the risk of thyroid C-cell tumors, based on animal studies
You don't need a rigid meal plan
Clinical studies have shown that individuals using semaglutide experience substantial weight loss, often exceeding that achieved with other medications
Preclinical studies demonstrated that GLP-1 receptor agonists increased bone formation and reduced bone resorption in metabolic bone disease models, including diabetic osteoporosis, postmenopausal osteoporosis, and glucocorticoid-induced osteoporosis
In addition, combined inhibition of Wnt, Notch, and epidermal growth factor receptor (EGFR) pathways, as well as combined inhibition of Wnt, Notch, and mitogen-associated protein kinase (MAPK), increase differentiation of Lgr5 + stem cells towards EECs and abolished differentiation of goblet cells and Paneth cells in intestinal Organoids [199] (Fig